NeoPharm
092730.KQ
7.58 USD
-0.23
-2.94%
n
Overview
Last close
7.58 usd
Market cap
60.54M usd
52 week high
11.32 usd
52 week low
7.28 usd
Target price
25.03 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.5612
Price/Book Value
1.0274
Enterprise Value
42.07M usd
EV/Revenue
0.5393
EV/EBITDA
1.9465
Key financials
Revenue TTM
60.35M usd
Gross Profit TTM
43.38M usd
EBITDA TTM
16.13M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
131.71M usd
Net debt
N/A usd
About
NeoPharm CO., LTD. manufactures and sells skin care products in South Korea. The company offers Atopalm, a non-steroid product for sensitive and dry skin; skin dermo-cosmetic products under the Real Barrier brand; products for sensitive, dry, oily, or trouble-prone skin under the ZEROID brand; body moisturizers under the Derma-B brand; and sport care products for athletes under the MISSION ATHELETCARE brand. NeoPharm CO., LTD. was founded in 2000 and is headquartered in Daejeon, South Korea.
- Symbol092730.KQ
- ExchangeKQ
- IsinKR7092730001
- CountrySouth Korea
- SectorConsumer Non-Cyclicals
- IndustryPersonal & Household Products & Services
- CEOByeong-Deog Park
- HeadquarterDaejeon
- Web sitehttps://www.neopharm.co.kr
